Pilot Study of the Effects of Erythritol on Endothelial Function in Patients With Type 2 Diabetes Mellitus
1 other identifier
interventional
24
1 country
1
Brief Summary
The study will determine whether acute and chronic consumption of a beverage containing erythritol will improve endothelial function in patients with type 2 diabetes mellitus.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable type-2-diabetes-mellitus
Started May 2012
Shorter than P25 for not_applicable type-2-diabetes-mellitus
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2012
CompletedFirst Submitted
Initial submission to the registry
May 25, 2012
CompletedFirst Posted
Study publicly available on registry
May 31, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2012
CompletedJuly 24, 2013
July 1, 2013
7 months
May 25, 2012
July 23, 2013
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Brachial artery flow mediated dilation
Change from baseline at 28 days
Secondary Outcomes (6)
Brachial artery flow-mediated dilation
Change from baseline at 2 hours
Reactive hyperemia
Change from baseline at 2 hours and 28 days
Carotid femoral pulse wave velocity
Change from baseline at 28 days
Fingertip tonometry
Change from baseline at 2 hours and 28 days
Urine F2 isoprostanes
Change from baseline at 28 days
- +1 more secondary outcomes
Study Arms (1)
Erythritol-containing beverage
EXPERIMENTALInterventions
Orange flavored beverage containing erythritol
Eligibility Criteria
You may qualify if:
- Type 2 diabetes mellitus
- Otherwise healthy
You may not qualify if:
- Pregnant
- BMI\>35 kg/m2
- Long acting insulin treatment
- Other major illness, drug abuse
- Treatment with an investigational drug within 12 weeks
- Treatment with dietary or vitamin supplements
- Smoking within 3 months
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Boston Universitylead
- Cargillcollaborator
Study Sites (1)
Boston University School of Medicine
Boston, Massachusetts, 02118, United States
Related Publications (1)
Flint N, Hamburg NM, Holbrook M, Dorsey PG, LeLeiko RM, Berger A, de Cock P, Bosscher D, Vita JA. Effects of erythritol on endothelial function in patients with type 2 diabetes mellitus: a pilot study. Acta Diabetol. 2014;51(3):513-6. doi: 10.1007/s00592-013-0534-2. Epub 2013 Dec 24.
PMID: 24366423DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Joseph A. Vita, MD
Boston University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor of Medicine
Study Record Dates
First Submitted
May 25, 2012
First Posted
May 31, 2012
Study Start
May 1, 2012
Primary Completion
December 1, 2012
Study Completion
December 1, 2012
Last Updated
July 24, 2013
Record last verified: 2013-07